Abstract:Raman spectroscopy (RS) has demonstrated its utility in neurooncological diagnostics, spanning from intraoperative tumor detection to the analysis of tissue samples peri- and postoperatively. In this study, we employed Raman spectroscopy (RS) to monitor alterations in the molecular vibrational characteristics of a broad range of formalin-fixed, paraffin-embedded (FFPE) intracranial neoplasms (including primary brain tumors and meningiomas, as well as brain metastases) and considered specific challenges when employing RS on FFPE tissue during the routine neuropathological workflow. We spectroscopically measured 82 intracranial neoplasms on CaF2 slides (in total, 679 individual measurements) and set up a machine learning framework to classify spectral characteristics by splitting our data into training cohorts and external validation cohorts. The effectiveness of our machine learning algorithms was assessed by using common performance metrics such as AUROC and AUPR values. With our trained random forest algorithms, we distinguished among various types of gliomas and identified the primary origin in cases of brain metastases. Moreover, we spectroscopically diagnosed tumor types by using biopsy fragments of pure necrotic tissue, a task unattainable through conventional light microscopy. In order to address misclassifications and enhance the assessment of our models, we sought out significant Raman bands suitable for tumor identification. Through the validation phase, we affirmed a considerable complexity within the spectroscopic data, potentially arising not only from the biological tissue subjected to a rigorous chemical procedure but also from residual components of the fixation and paraffin-embedding process. The present study demonstrates not only the potential applications but also the constraints of RS as a diagnostic tool in neuropathology, considering the challenges associated with conducting vibrational spectroscopic analysis on formalin-fixed, paraffin-embedded (FFPE) tissue.

Harnessing topological machine learning in Raman spectroscopy: Perspectives for Alzheimer's disease detection via cerebrospinal fluid analysis

Alzheimer Disease Detection from Raman Spectroscopy of the Cerebrospinal Fluid via Topological Machine Learning

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

Characterization of Local White Matter Microstructural Alterations in Alzheimer’s Disease: A Reproducible Study

A Multi-Year Label-Free In Vitro Raman Spectroscopy Study Empowered by Chemometrics

Raman spectroscopy and topological machine learning for cancer grading

Early Detection of Alzheimer’s Disease Using Non-invasive Near-Infrared Spectroscopy

Machine Learning-Assisted Classification of Paraffin-Embedded Brain Tumors with Raman Spectroscopy

Neuroinflammation and Alzheimer’s Disease: A Machine Learning Approach to CSF Proteomics

Applications of Raman spectroscopy in the diagnosis and monitoring of neurodegenerative diseases

Research on Voxel-Based Features Detection and Analysis of Alzheimer's Disease Using Random Survey Support Vector Machine

Ultrasensitive Detection of Blood-Based Alzheimer's Disease Biomarkers: A Comprehensive SERS-Immunoassay Platform Enhanced by Machine Learning

Multi-branch attention Raman network and surface-enhanced Raman spectroscopy for the classification of neurological disorders

Multi-scale sequential feature selection for disease classification using Raman spectroscopy data

Unveiling brain disorders using liquid biopsy and Raman spectroscopy

Beyond group classification: Probabilistic differential diagnosis of frontotemporal dementia and Alzheimer's disease with MRI and CSF biomarkers

Association between Structural Connectivity and Generalized Cognitive Spectrum in Alzheimer's Disease

Raman Spectroscopy on Brain Disorders: Transition from Fundamental Research to Clinical Applications

Analysis of convolutional neural networks for fronto-temporal dementia biomarker discovery

Accuracy of Raman Spectroscopy in the Diagnosis of Alzheimer's Disease

Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients?